The vaccine, Mosquirix or RTS,S, was developed by GSK and the non-profit PATH, and was the first malaria vaccine to get ...

Congressional lawmakers are trading millions in pharmaceutical stocks as the Trump administration vies to overhaul the ...

This builds upon its initial approval in May 2024 for adults aged 60 years and older, which makes mRESVIA the second approved ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

A few of the new members Health Secretary Robert F. Kennedy Jr. appointed to the federal panel have promoted misinformation ...

Since Robert F. Kennedy Jr. fired the members of the CDC’s esteemed vaccine advisory panel, medical organizations and experts ...

The moves come as Kennedy has replaced members of the key federal vaccine advisory panel to the Centers for Disease Control ...

Merck & Co., Inc. (NYSE:MRK) is another biopharmaceutical company on the list of the 10 undervalued blue chip stocks analysts ...

But one of the standout moments during the hearing occurred when Kennedy suggested that a sitting member of Congress only ...

Wednesday’s meeting of the influential vaccine panel will show whether Secretary Kennedy, who was called a ‘liar’ at a budget ...

Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments ...

Hong Kong-based Regencell has seen its stock explode higher this year on essentially no news.